AU697710B2 - Oxidation of phosphorus compounds - Google Patents

Oxidation of phosphorus compounds

Info

Publication number
AU697710B2
AU697710B2 AU73122/96A AU7312296A AU697710B2 AU 697710 B2 AU697710 B2 AU 697710B2 AU 73122/96 A AU73122/96 A AU 73122/96A AU 7312296 A AU7312296 A AU 7312296A AU 697710 B2 AU697710 B2 AU 697710B2
Authority
AU
Australia
Prior art keywords
groups
group
process according
formula
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU73122/96A
Other versions
AU7312296A (en
Inventor
Judith Elizabeth Browne
Michael John Driver
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Vascular Devices Ltd
Original Assignee
Biocompatibles Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9521233.8A external-priority patent/GB9521233D0/en
Priority claimed from GBGB9521234.6A external-priority patent/GB9521234D0/en
Application filed by Biocompatibles Ltd filed Critical Biocompatibles Ltd
Publication of AU7312296A publication Critical patent/AU7312296A/en
Application granted granted Critical
Publication of AU697710B2 publication Critical patent/AU697710B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/657154Cyclic esteramides of oxyacids of phosphorus
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/091Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/141Esters of phosphorous acids
    • C07F9/1411Esters of phosphorous acids with hydroxyalkyl compounds with further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/22Amides of acids of phosphorus
    • C07F9/24Esteramides
    • C07F9/2404Esteramides the ester moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/2408Esteramides the ester moiety containing a substituent or a structure which is considered as characteristic of hydroxyalkyl compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5407Acyclic saturated phosphonium compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/657109Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms esters of oxyacids of phosphorus in which one or more exocyclic oxygen atoms have been replaced by (a) sulfur atom(s)
    • C07F9/657118Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms esters of oxyacids of phosphorus in which one or more exocyclic oxygen atoms have been replaced by (a) sulfur atom(s) non-condensed with carbocyclic rings or heterocyclic rings or ring systems

Description

Oxidation of Phosphorus Compounds
The present invention relates to a process in which a phosphite triester compound is oxidised to form the corresponding phosphate triester derivative, that is a phosphorus V compound. The process uses a tertiary amine oxide as oxidant and the tertiary amine byproduct is used as a reactant in a subsequent step such as removal of a protecting group or displacement of a halogen atom.
There are various synthetic processes in which phosphite ester compounds are oxidised so as to produce a corresponding phosphorus V compound. For instance, various synthetic processes starting with phosphorous trichloride as starting material pass through phosphite ester intermediates in a multi-step process to form phosphate ester products. Such processes are used in the synthesis of phospholipid derivatives, glycolipid derivatives and nucleic acids. Cyclic diesters, such as 1,3,2- dioxaphospholanes and 1,3,2-dioxaphosphorinanes may be oxidised to form the corresponding 2-oxo derivatives. Edmundson et al, in Che . and Ind (1966) 1828 to 1829 describe the use of molecular oxygen in benzene as a successful oxidising agent, especially for phospholanes. Dinitrogen tetroxide had also been used as an oxidising agent.
In nucleic acid synthesis a phosphite triester is generally oxidised using aqueous iodine in the presence of pyridine or 2,6-lutidine to form the corresponding phosphate triester. Iodine cannot be used in non aqueous systems and so is of no use for oxidising phosphorus III compounds which have substituents which are sensitive to water. For instance it would be of no use for oxidising a phospholane or phosphorinane compound such as those described by Edmundson op. c±t .
Other oxidising agents have been described for oxidising phosphite ester compounds in nucleic acid synthesis, some of which may be used in non-aqueous solvent systems. Examples of non-aqueous oxidising agents used in nucleic acid synthesis include dinitrogen tetroxide, tertiary-butyl hydroperoxide, ditertiary-butyl hydroperoxide, cumene hydroperoxide, hydrogen peroxide, bis-(trimethylsilyl) peroxide in the presence of catalytic amounts of trimethylsilyl triflate, m-chloroperbenzoic acid, dimethyl sulphoxide, trimethyla ine N-oxide, pyridine-N-oxide, N-methylmorpholine-N-oxide, iodobenzene diacetate, tetra-n-butylammonium periodate and oxygen in the presence of free radical generators. However aqueous iodine continues to be the reagent of choice for the oxidation of nucleotide phosphite triesters.
Noyori and colleagues in Tet.Lett (1986) 27(35),4191- 94, (Hayakawa et al) described various non-aqueous oxidation processes for phosphite triesters, including the amine oxide compounds, trimethylamine N-oxide, N-
- methylmorpholine-N-oxide and pyridine-N-oxide. The yields with the first and third mentioned amine oxides were extremely low, even after long reaction times. The yield with the second mentioned compound was reasonable. It would be desirable to provide a process in which amine oxides are used as oxidising agents which will give a high phosphate yield. In Bull.Soc.Chim.Fr. (1974) issue 3-4, 677-680 Branlt and Chabrier describe the oxidation of cyclic phosphite triesters and the subsequent silultaneous fing opening and amination of the corresponding phosphate triester to form phosphoryl choline derivatives. The phosphite triester is a diester of optionally substituted cathylene glycola or 1,3-propandiol with the third al oxy group being selected from ethoxy, 0-acetylphenoxy, phenoxy and methoxy. The oxidising agent is trimethyla ineoxide. In C.R. Acad.Sci.Paris, Ser C (CHDCAQ) (1973), 276 (13), 1135-7, Chabrier and Branlt there is a further disclosure of the oxidation of various mono methoxy cyclic phosphite triesters using tertiary amine oxide. In a new process according to the present invention for forming phosphotriester compounds: a phosphite triester of the formula I
BR70 - P - OR4 I 5 I
OR
in which R is a straight or branched alkylene, oxoalkylene or oligo-oxaalkylene chain and B is an ethylenically unsaturated poly erisable group selected from
wherein:
R is hydrogen or a C.--C,, alkyl group; g a
A is -O- or -NR - where R is hydrogen or a C|-C4 alkyl group; and
K is a group -(CH2)pOC(0)-, -(CH2)pC(O)0-,
-(CH2)pOC(0)0-, -(CH2)pNR9-, - (CH-) pOC (O) NR9- ,
-(CH2) NR C(0)NR -, (in which the groups R are the same or different) , -(CH2)pO-, -(CH2) S03 -, or a valence bond and p is from 1 to 12 and R is hydrogen or a C1-C4 alkyl group; and
R 4 and R5 are the same or different and each is selected from C1.40 straight or branched-alkyl groups, - alkenyl groups and -alkynyl groups, any of which may be unsubstituted or substituted by aryl groups, hydroxyl groups, halogen atoms, amine (including mono-, di- or tri- alkyl substituted amine) groups, sulphonium, thiol, carboxylic acid or phosphoniu groups, or R 4 and R5 may, together, with the oxygen atoms to which they are attached and the phosphorus atom form a 5 to 15 membered heterocyclic ring, optionally containing additional hetero atoms and/or substituents at ring carbon and/or nitrogen atoms (if any) , is oxidised in solution by an oxidising agent to form the corresponding phosphate triester of the formula II
are as defined for formula I. Although it may be possible to use conventional oxidising agents such as have been used in the prior art for oxidising phosphite triesters and are mentioned in the above prior art discussion, we have found that some of these attack the ethylenic bond in the group B. Thus, in a preferred aspect, the oxidising agent is a tertiary amine oxide Z → O, whereby the corresponding tertiary amine Z is produced as a byproduct. This allows the compound of the formula II and the tertiary amine to be reacted together in a subsequent step to produce a compound of the formula III
- BR70 - P - OR6 III
in which R is as defined above for formula I, Y is -θ" or OH and R 6 i.s ei.ther R4 or, where R5 and R4 together with the oxygen and phosphorus atoms to which they are attached, are joined to form a heterocyclic ring in the compound of the formula II and Y is -θ' or OH in the compound III, is a group +ZR5R - in which R4R5 represent the groups as defined for compound of the formula II and Z is as defined in the tertiary amine oxide above provided that R is not R when Y is OR5.
In this aspect of the process the tertiary amine oxide which is used as the oxidising agent for the phosphite triester may be any suitable tertiary amine oxide. Examples of suitable amine oxides are trialkylamine oxides in which the alkyl groups are each lower alkyl, for instance trimethylamine-N-oxide or may be a heterocyclic amine, for instance based on an unsaturated heterocyclic ring such as a pyridine ring, or a saturated ring system such a N-lower alkyl morpholine ring. The tertiary amine oxide may therefore be pyridine-N-oxide or N-methyl morpholine-N-oxide. Preferably the tertiary amine oxide is trimethylamine-N-oxide.
The two step process of the preferred embodiment of the present invention allows the oxidised intermediate produced in situ immediately to be further reacted with the byproduct of the oxidation reaction in a further step. The further step may be a base catalysed deprotection step, in which a protecting group R is removed from the phosphate. Alternatively, the reaction may be an amination reaction,
4 for instance, of a halo-substituted alkyl group R to produce the corresponding quaternary ammonium compound. In a further example, the tertiary amine is used in a simultaneous deprotection and amination reaction where the groups R 4 and R5 are j.oi.ned to one another to form a heterocyclic ring with the oxygen atoms to which they are attached and the phosphorus atom, thereby forming a ring
- opened phosphate diester in which the group R contains a quaternary ammonium group (i.e. is a group R 4R5Z+). In any of such subsequent steps, it may be desirable to include additional tertiary amine reactant, which is usually the same as the tertiary amine byproduct. It may also be desirable to add additional solvent and/or to remove some or all of the solvent from the first step. Preferably, however, no solvent is removed after the first step.
R is preferably unsubstituted lower alkyl or halogen- substituted lower alkyl, or together with R forms a 5-7- membered ring. In the present invention the group R is preferably a C1.6 alkyl group or an aryl group, preferably substituted with one or more electron withdrawing groups, such as halogen atoms, nitro groups, cyano groups, sulphonyl groups, and aryl (including heteroaryl) groups. Substituents in R may additionally provide steric hindrance (for instance 1,1-dialkyl substituents on an alkyl group) . Although R may represent a methyl group, it preferably represents a lower alkyl group with an electron withdrawing substituent such as an aryl group, a cyano group or a vinyl group. Preferred groups R5 are allyl, benzyl, phenyl, phenylsulphoethyl, methyl-sulphoethyl, para-nitrophenylethyl, 2,2,2-trihaloethyl (especially trichloro- and tribromo-ethyl) , 2,2,2-trihalo-l,1,- dialkylethyl (especially 2 , 2 , 2 , -trichloro-1, 1- dimethylethyl, 2'-and 4'-pyridylethyl, jπ- ethylbenzyl, p- or m-halobenzyl, m,p-dichlorobenzyl, pentahalophenyl (especially pentafluoro- and pentachloro-phenyl) 2,6- dimethylphenyl and 2, -dinitrophenyl and, most preferably, beta-cyano ethyl. In another preferred aspect of the invention the group R 5 i.s joined to the group R4 to form an ethylene or higher poly(methylene) group. R is preferably unsubstituted lower alkyl (C,^ - alkyl) or halogen substituted lower alkyl. Alternatively
R and R together are ~(CH2)2.6-, preferably -(CH2)2-.
In the compound of the formula I B is preferably a group of the formula CH2=C(R)-CO-A-. Preferably R is hydrogen or methyl, preferably methyl. A may be -NR -, but is preferably -0-. R is preferably -(CH2)2.6-, preferably
—CH2—CH —•
Suitable solvents for the oxidation step include nitrile derivatives of lower carboxylic acids, especially acetonitrile, and other aprotic solvents such as dimethyl forma ide and dimethyl acetamide. The use of acetonitrile, where the oxidising agent is tertiary amine oxide is found to give excellent yields and low levels of by product formation which is surprising especially in view of the observation by Hayakawa et al (op cit) that such solvents give poor results.
Suitable solvents for a step of the process following the oxidation step are acetonitrile, as well as mixtures of acetonitrile and dichloromethane, methanol/chloroform mixtures or even aqueous lower alcohol mixtures.
The invention is illustrated further in the following examples. Examples 3 to 5 show the use of oxidising agents other than tertiary amine oxide in the first step of the process. These show that the rate of the oxidation step of the preferred embodiment of the present invention using amine oxide and its yields are comparable to those using commonly used non-aqueous oxidising agents, meta-chloroperbenzoic acid, dinitrogen tetroxide and tertiary butyl hydroperoxide. The results also show that the use of amine oxide oxidising agents in the preferred embodiment of the present invention facilitates further reaction steps and precludes the need to isolate reaction intermediates. Example l
Large scale preparation of 2-(methacryloyloxyethyl)-2'- trimethylammoniumethyl) phosphate, inner salt 1.1 N.N-Diisopropylaminoethylene phosphite
Diisopropylamine (463 g, 4518 mmol) was added dropwise over one hour to a stirred solution of 2-chloro-l,3,2- dioxaphospholane (distilled, 115.8 g, 915 mmol) in anhydrous ether (4000 ml) at -10°C under nitrogen. The mixture was allowed to return to room temperature and was stirred for 16 hours, filtered to remove diisopropylammonium chloride and the filter bed washed with ether (400 ml) . The filtrate and washings were evaporated to ca 500 ml and the mixture was refiltered and the filter bed was washed with ether (1400 ml) . The solvent was removed to give a mobile liquid which was filtered through a sinter funnel and fractionally distilled (40°C, 0.1 mbar) to give pure N,N-diisopropylaminoethylene phosphite , 104.2 g, 545 mmol, 60% yield. H-nmr , 200 MHz , ( CDC13) δ 1 . 17 (d) , 3 . 46 (m) , 3 . 89 (m) , 4 . 14 ( )
1.2 2- r (Methacryloyl) ethyloxy") -1.3 , 2 -dioxaphospholane
A mixture of 4,5-dichloroimidazole (70 g, 511 mmol) and 2- hydroxyethyl methacrylate (68.0 g, 523 mmol) was dissolved in dry acetonitrile (500 ml) . N,N-Diisopropylaminoethylene phosphite (100 g, 523 mmol ) in dry acetonitrile (100 ml) was added dropwise over one hour under a nitrogen atmosphere at room temperature and was then stirred for ten
__ inutes. The mixture was filtered through a tightly packed bed of Celite and the pad was washed with acetonitrile (200 ml) to give a solution of 2-[ (methacryloyl)ethyloxy] - 1,3,2-dioxaphospholane which was used immediately.
1.3 2-r (Methacryloyli ethyloxyl -2-oxo-l.3.2- dioxaphospholane
The solution of 2-[ (methacryloyl)ethyloxy]-1,3,2- dioxaphospholane in acetonitrile (800ml) was cooled to - 10°C and a solution of anhydrous trimethylamine-N-oxide (35.4 g, 471 mmol) in acetonitrile (200 ml) was added dropwise under nitrogen over 90 minutes. The mixture was allowed to warm to room temperature and the solvent was evaporated to ca 800 ml to give a solution of 2- [ (methacryloyl) ethyloxy ] -2-oxo-l , 3 , 2-dioxaphospholane which was used immediately . A sample was analysed by H-nmr.
1H-nmr , 200 MHz , (CDC13) <S = 1. 97 (s) , 4 . 43 (m) , 5. 66 (s) , 6.21 (s)
Tic of the product showed it to be clean with few by products apparent.
1.4 2-(Methacryloyloxyethyl)-2 '-trimβthylammoniumethyl) phosphate, inner salt
The solution of 2-[ (methacryloyl)ethyloxy]-2-oxo-l,3,2- dioxaphospholane was treated with trimethylamine (49.9 g, 845 mmol) in dry acetonitrile (200 ml) and stirred at 50°C for 16 hours. The mixture was cooled to ambient temperature and some of the excess trimethylamine was removed under reduced pressure. The solution was warmed to 80°C, filtered through a bed of Celite under nitrogen . After cooling a total of 300 ml of acetonitrile was removed under reduced pressure, and the solid was isolated after crystallisation to give pure 2-(methacryloyloxyethyl)-2'- trimethylammoniumethyl) phosphate, inner salt, 35.0 g, 119 mmol, 23 % yield from 2-hydroxyethyl methacrylate.
'H-nmr, 200 MHz, (D20) ό" = 1.94 (s) , 3.21 (s) , 3.66 (m) , 4.17 (m) , 4.31 ( ) , 4.39 (m) , 5.76 (s) , 6.19 (s)
13 C-nmr, 50.1 MHz, (D20) δ - 20.2, 56.8, 62.3, 66.7, 67.3, 68.8, 129.9, 138.7, 172.4 Example 2
2-f(Mβthacryloyl)ethyloxy1-1,3.2-dioxaphospholane
and 2-hydroxyethylmethacrylate (6.8 g, 52.3 mmol) was dissolved in dry acetonitrile (100 ml) . N,N- Diisopropylaminoethylene phosphite (10 g, 52.3 mmol) was added under a nitrogen atmosphere at room temperature and stirred for ten minutes. The mixture was filtered through a tightly packed bed of Celite and the pad was washed with acetonitrile (ca 20 ml) to give a solution of 2- [ (methacryloyl)ethyloxy] -1,3,2-dioxaphospholane which was used immediately.
-'Hnmr, 200 MHz, (CDC13) δ = 1.97(s), 4.01(m), 4.25(m),
5.62(s) , 6.20(s)
2-r (Methacryloyl)ethyloxy!-2-oxo-l.3.2-dioxaphospholane
The solution of 2-[ (methacryloyl)ethyloxy] -1,3,2- dioxaphospholane in acetonitrile (25 ml) was cooled to 0°C and a solution of trimethylamine-N-oxide (3.54 g, 47.1 mmol) in acetonitrile (10 ml) was added dropwise under nitrogen. The mixture was allowed to warm to room temperature to give a solution of 2- [ (methacryloyl)ethyloxy]-2-oxo-l,3,2-dioxaphospholane which was used immediately. A sample was analysed by H-nmr.
1H-nmr, 200 MHz, (CDC13) δ = 1.96(s), 4.43(m), 5.63(s), 6.21(s) Tic of the produce showed it to be clean , without significant by products .
2 - (Methacryloyloxyethyl ) -2 ' trimethylammoniuaethyl ) hosphate, inner salt
The solution of 2-[ (methacryloyl)ethyloxy]-2-oxo-l,3,2- dioxaphospholane was treated with trimethylamine (4.64 g, 78.0 mmol) in dry acetonitrile (20 ml) and stirred at 50°C for 48 hours. The mixture was cooled to ambient temperature and evaporated to about half its volume. The mixture was cooled to -20°C for 16 hours. The mixture was filtered through filter paper under nitrogen and washed with acetonitrile (13 ml) . The solid was isolated after
- crysallisation to give pure 2-(Methacryloyloxyethyl)-2'- trimethyl-am oniumethyl) phosphate, inner salt, 4.16 g, 14.1 mmol, 27% yield from 2-hydroxyethyl methacrylate.
1H-nmr, 200 MHz, (D20) δ = l.94(s), 3.21(s), 3.67(m) , 4.17(m) , 4,30(m) , 4.39(m) , 5.75(s), 6.19(s) .
A second crop of material was crystallised which was purified by column chromatography on silica (150 g) , eluting with ethanol to give pure material, 3.87g, 13.0 mmol, 25% yield from 2-hydroxyethyl methacrylate.
1H-nmr, 200 MHz, (D20) δ = 1.93(s), 3.19(s), 3.64(m), 4.14(m), 4.29(m), 4.39(m), 5.74(s), 6.19(s)
Total yield (based on 2-hydroxyethylmethacrylate) was 52%. Rvample 3
2 - (Methacryloγloxyethyl ) -2 ' -trimethylam oniumethyl ) phosphate, inner salt usinσ metachloroperbenzoic acid oxidant
2-Hydroxyethylmethacrylate (0.43 g, 3.32 mmol) and 4,5- dichloroimidazole (0.45 g, 3.32 mmol) were stirred in dry acetonitrile (10 ml) in the presence of 4A molecular sieves (1 g) . Bis(diisopropylamino)-cyanoethylphosphine (1 g, 3.32 mmol) was added to the mixture which was stirred under nitrogen at room temperature for 4 hours to give the crude monophosphoramidite.
'H-nmr, 200 MHz, (CDC13) ό" = 1.18 (d) , 1.94 (s) , 2.62 (t) , 3.60 (m) , 3.84 (m) , 4.30 (t) , 5.60 (s) , 6.14 (s)
Bromoethanol (redistilled, 0.41 g, 3.32 mmol), 4,5- dichloroimidazole (0.45 g, 3.32 mmol) and 4A molecular sieves (l g) were added to the reaction mixture and stirred at room temperature for 16 hours. A further quantity of bromoethanol (redistilled, 0.05 g, 0.40 mmol) was added and the mixture was stirred at 40°C for four hours. After filtering through celite and a 0.2 μm glass fibre filter, the solvent was removed to give crude triphosphite.
1H-nmr, 200 MHz, (CDC13) <5 = 1.43 (d) , 1.94 (s) , 2.68 (t) , 3.50 (t) , 4.11 (m) , 4.34 (t) , 5.62 (s) , 6.17 (s)
The crude triphosphite was dissolved in dichloromethane (20 ml) and treated with meta-chloroperbenzoic acid (0.57 g, 3.32 mmol) and stirred at room temperature for ten minutes. The solution was extracted with saturated aqueous sodium bicarbonate ( 4 x ca 20 ml) . The combined aqueous layers were back extracted with dichloromethane (ca 40 ml) which was pooled with the earlier organic fraction and re- extracted with saturated aqueous sodium bicarbonate ( 2 x ca 20 ml) . The mixture was dried over magnesium sulphate and evaporated to give the crude triphosphate, 1.18 g, 3.19 mmol, 96% yield from 2-hydroxyethyl methacrylate.
H-nmr, 200 MHz, (CDC13) <5 = 2.00 (s) , 2.80 (t) , 3.54 (t) , 4.37 ( ) , 5.65 (s) , 6.19 (s)
Tic of the product showed significant by products, believed to be due to by products in which the oxidising agent attacks the ethylenically unsaturated group. Thus the product is not as clean as when using the amine oxide oxidising agent.
The crude triphosphate (1.18 g, 3.19 mmol) was dissolved in dry acetonitrile (ca 30 ml) and treated with trimethylamine (1.57 g, 26.5 mmol) in a sealed vessel and heated at 75°C for 48 hours. 4A molecular sieves (1.5 g) were added to the mixture and heating was maintained for a further two hours before filtering through celite and a 0.2 μ glass fibre filter . The solvent was evaporated and the residue dissolved in methanol and purified by column chromatography on silica gel (ca 20 g) eluting with methanol. Fractions containing product were combined and evaporated to dryness to give pure 2- (methacryloyloxyethyl) -2 ' - (trimethylammoniumethyl) phosphate, inner salt, 0.29 g, 0.97 mmol, 30% yield.
1H-nmr, 200 MHz, (D20) <S = 1.96 (s) , 3.23 (s) , 3.67 (m) , 4.17 (m) , 4.31 (m) , 4.40 (m) , 5.76 (s) , 6.20 (s)
The overall yield of 2-(methacryloyloxyethyl)-2'- trimethylammoniumethyl) phosphate, inner salt from 2- hydroxyethylmethacrylate was 29%.
Example 4
2 - r (Methacryloyl) ethyloxyl -2-oxo-l . 3 .2 -dioxaphospholane using dinitroσen tetroxide oxidisinσ agent
o Dinitrogen tetroxide was purified using the method of MS Anson and C McGuigan (J. Chem. Soc. Perkin Trans. 1, 1989, 715). A solution of dinitrogen tetroxide (0.175 g, 1.92 mmol) in dry dichloromethane (12 ml) was added dropwise to a solution of 2-[ (methacryloyl) ethyloxy]-1,3,2- dioxaphospholane (produced as in example 1.2) (1.69 g, 7.68 mmol) in dry dichloromethane at -60°C. After leaving for five minutes the mixture was allowed to warm to room temperature and the solvent was evaporated to give crude 2- [ (methacryloyl)ethyloxy]-2-oxo-l,3,2-dioxaphospholane (1.86 g, 7.8 mmol) which was used immediately (for example in a step corresponding to example 1.4).
H-nmr, 200 MHz, (CDC13) δ = 1.97 (s) , 4.44 ( ) , 5.63 (s) , 6.21 (s)
Tic of the product showed it was less clean than that of examples 1 and 2.
Example 5
2-r (Methacryloyl)ethyloxy1-2-oxo-l.3.2-dioxaphospholane using t-butyl hydroperoxide oxidising agent
A solution of tert-butylhydroperoxide in decane (5.5 M, 1.40 ml, 7.68 mmol) in dry dichloromethane (15 ml) was added dropwise to a solution of 2-[ (methacryloyl)ethyloxy] -1,3,2-dioxaphospholane (1.69 g, 7.68 mmol) (produced in example 7.2) in dry dichloromethane (15 ml) at 0°C. After leaving for five minutes the mixture was allowed to warm to room temperature and the solvent was evaporated and the residue dried under vacuum to give crude 2- [ (methacryloyl)ethyloxy]-2-oxo-l,3,2-dioxaphospholane which was generally used immediately (for instance for a step corresponding to example 1.4).
'H-nmr, 200 MHz, (CDC13) δ = 1.97 (s) , 4.46 (m) , 5.63 (s) , 6.21 (s)
Tic of the product showed it was less clean than that of examples 1 and 2.
Byaw e fi Preparation of 2 - ( meth crv 1ov1oxyβthv 1 ) - 2 ' (trimethγlamoniumethyl) hosphate inner salt
A solution of 2-chloro-l, 3,2-dioxaphospholane (4.9g, 0.04M) in acetonitrile was cooled to -10°C under a nitrogen atmosphere when 2,6 - dimethylpyridine (4.0g, 0.04M) was added over 20 minutes. The mixture was stirred at -10°C for a further 20 minutes. A solution of 2-hydroxyethyl methacrylate (4.4g, 0.033M) in acetonitrile (8ml) was added
- over 15 minutes at -10CC. The mixture was allowed to warm to 0°C and was filtered. The filtrate was cooled to -10°C and treated with a solution of trimethylamine N-oxide (2.4g, 0.32M) in acetonitrile (25ml). A solution of trimethylamine (3.3g) in acetonitrile (10ml) was added. The mixture was heated in a closed system at 45°C for 16 hours to give the desired product which was isolated by concentrating the reaction mixture and crystallisation at 0°C.
Tic showed that the product was clean and contaminated by low quantities of by products. 'H-nmr, 200 MHz, (D20) δ = 1.94 (s) , 3.21 (s) , 3.66 ( ) , 4.17 (m) , 4.31 (m) , 4.39 (m) , 5.76 (s) , 6.19 (s)
13C-nmr, 50.1 MHz, (D20) δ = 20.2, 56.8, 62.3, 66.7, 67.3,
68.8, 129.9, 138.7, 172.4
°γ

Claims (1)

  1. 1. A process of forming phosphotriester compounds wherein: a phosphite triester of the formula I
    in which R is a straight or branched alkylene, oxoalkylene or oligo-oxaalkylene chain and B is an ethylenically unsaturated polymerisable group selected from
    wherein:
    R is hydrogen or a C,-^ alkyl group; A is -O- or -NR 8- where R8 is hydrogen or a C^-C^ alkyl
    - group; and
    K is a group -(CH2)pOC(0) -, -(CH2)pC(0)0-,
    -(CH2)p0C(0)0-, -(CH2)pNR9-, - (CH2) pOC (O) NR9- ,
    -(CH2)pNR9C(0)NR9-, (i.n whi.ch the groups R9 are the same or different), -(CH2)pO-, -(CH2) S03 -, or a valence bond and p is from 1 to 12 and R 9 is hydrogen or a C,-^ alkyl group; and
    R 4 and R5 are the same or different and each is selected from C,_40 straight or branched-alkyl groups, - alkenyl groups and -alkynyl groups, any of which may be unsubstituted or substituted by aryl groups, hydroxyl groups, halogen atoms, amine (including mono-, di- or tri- alkyl substituted amine) groups, sulphonium, thiol, carboxylic acid or phosphonium groups, or R 4 and R5 may, together, with the oxygen atoms to which they are attached and the phosphorus atom form a 5 to 15 membered heterocyclic ring, optionally containing additional hetero atoms and/or substituents at ring carbon and/or nitrogen atoms (if any) , is oxidised in solution by an oxidising agent to form the corresponding phosphate triester of the formula II
    O
    in which R 7, B, R4 and R5 are as defined for formula I.
    2. A process according to claim 1 characterised in that the oxidising agent is a tertiary amine oxide Z -* O, whereby the corresponding tertiary amine Z is produced as a byproduct. . A process according to claim 2 in which the compound of the formula II and the tertiary amine by product are reacted together in a subsequent step to produce a compound of the formula III
    O
    in which B and R are the same groups as in the compound of the formula II, Y is -O* or OH or OR , in which R is as defined in claim 1, and R is either R or, where
    R 5 and R4 together with the oxygen and phosphorus atoms to which they are attached, are joined to form a heterocyclic ring in the compound of the formula II and Y is -o" or OH in the compound III, is a group +ZR5R4- in which R4R5 represent the groups as defined for compound of the formula
    II and Z is as defined in the tertiary amine oxide above, provided that R is not R4 when Y is OR5.
    4. A process according to claim 3 in which the said subsequent step comprises a base-catalysed deprotection step in which a protecting group OR5 is replaced by o" or OH (ie Y is θ' or OH) .
    5. A process according to claim 3 or claim 4 in which the said subsequent step comprises an amination reaction in which a compound II in which R4 represents a halo-alkyl group is reacted to substitute an ammonium group for the halogen atom.
    6. A process according to claim 3 in which R4 and R are joined to one another to form a heterocyclic ring with the oxygen atoms to which they are attached and the phosphorous atom and in which the said subsequent step is a simultaneous ring opening and amination reaction which produces a compound III in which R is a group RRZ*.
    7. A process according to any of claims 3 to 6 in which the solvent for the oxidation step and for the said subsequent step is the same, and is preferably acetonitrile.
    8. A process according to any of claims 2 to 7 in which Z -♦ O is a trialkylamine oxide, preferably in which each alkyl group is lower alkyl, or a saturated or unsaturated heterocyclic amine oxide, preferably pyridine-N-oxide or N- lower alkyl morpholine-N-oxide, most preferably being -trimethylamine-N-oxide.
    9. A process according to any preceding claim in which R is a C1.6 alkyl group or an aryl group preferably substituted with one or more electron withdrawing groups, such as halogen atoms, nitro groups, cyano groups, sulphonyl groups, and aryl (including heteroaryl) groups.
    10. A process according to claim 9 in which R is selected from allyl, benzyl, phenyl, phenylsulphoethyl, methyl- sulphoethyl, para-nitrophenylethyl, 2,2,2-trihaloethyl (especially trichlorol-and tribromo-ethyl) , 2,2,2-trihalo- 1,1,-diaIky1ethyl (especially 2,2,2,-trichloro-l,1- dimethylethyl, 2'-and 4'-pyridylethyl, jji-methylbenzyl, p-or m-halobenzyl, ra,p-dichlorobenzyl, pentahalophenyl (especially pentafluoro- and pentachloro-phenyl) 2,6- dimethylphenyl and 2,4-dinitrophenyl and, most preferably, beta-cyano ethyl.
    11. A process according to any preceding claim wherein B is a group of the formula
    R 0
    CH2 = C I-CII-A- in which R is hydrogen or methyl, preferably methyl and A is preferably -0-; and
    R is (CH2)2.6, preferably (CH2)2.
    12. A process according to any preceding claim in which R 4 is unsubstituted lower alkyl or halogen-substituted lower alkyl.
    13. A process according to claim 1 or claim 6 in which R 4 and R together are (CH2)2.6, preferably (CH2)2.
AU73122/96A 1995-10-16 1996-10-16 Oxidation of phosphorus compounds Ceased AU697710B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9521233.8A GB9521233D0 (en) 1995-10-16 1995-10-16 Oxidation of phosphorus compounds
GBGB9521234.6A GB9521234D0 (en) 1995-10-16 1995-10-16 Synthesis of polymerisable phospho diesters
GB9521233 1995-10-16
GB9521234 1995-10-16
PCT/GB1996/002541 WO1997014702A1 (en) 1995-10-16 1996-10-16 Oxidation of phosphorus compounds

Publications (2)

Publication Number Publication Date
AU7312296A AU7312296A (en) 1997-05-07
AU697710B2 true AU697710B2 (en) 1998-10-15

Family

ID=26307962

Family Applications (1)

Application Number Title Priority Date Filing Date
AU73122/96A Ceased AU697710B2 (en) 1995-10-16 1996-10-16 Oxidation of phosphorus compounds

Country Status (7)

Country Link
EP (1) EP0863908A1 (en)
JP (1) JPH11513682A (en)
KR (1) KR19990064280A (en)
CN (1) CN1202898A (en)
AU (1) AU697710B2 (en)
CA (1) CA2233160A1 (en)
WO (1) WO1997014702A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011075185A1 (en) 2009-12-18 2011-06-23 Oligasis Targeted drug phosphorylcholine polymer conjugates
CN102659843B (en) * 2012-04-24 2015-06-24 北京大学 D, L-guanosine nucleoside analog monophosphate, and preparation method and application thereof
JP6463361B2 (en) 2013-09-08 2019-01-30 コディアック サイエンシーズ インコーポレイテッドKodiak Sciences Inc. Factor VIII zwitterionic polymer conjugate
US9840553B2 (en) 2014-06-28 2017-12-12 Kodiak Sciences Inc. Dual PDGF/VEGF antagonists
JP6849590B2 (en) 2014-10-17 2021-03-24 コディアック サイエンシーズ インコーポレイテッドKodiak Sciences Inc. Butyrylcholinesterase amphoteric ionic polymer conjugate
KR20180104635A (en) 2015-12-30 2018-09-21 코디악 사이언시스 인코포레이티드 Antibodies and conjugates thereof
AU2018250695A1 (en) 2017-04-14 2019-11-07 Kodiak Sciences Inc. Complement factor D antagonist antibodies and conjugates thereof
CN114786731A (en) 2019-10-10 2022-07-22 科达制药股份有限公司 Methods of treating ocular disorders

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7312196A (en) * 1995-10-16 1997-05-07 Biocompatibles Limited Synthesis of polymerisable phosphodiesters

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2270887A1 (en) * 1974-05-16 1975-12-12 Chabrier De Lassauniere Pierre Prepn of lecithins and glycol-lecithins - by reaction of trimethylamine with 2-substd-2-oxo-1,3,2-dioxaphospholans
GB9324033D0 (en) * 1993-11-23 1994-01-12 Biocompatibles Ltd Ethylenically unsaturated compounds
WO1995014701A1 (en) * 1993-11-23 1995-06-01 Biocompatibles Limited Ethylenically unsaturated compounds

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7312196A (en) * 1995-10-16 1997-05-07 Biocompatibles Limited Synthesis of polymerisable phosphodiesters

Also Published As

Publication number Publication date
WO1997014702A1 (en) 1997-04-24
CN1202898A (en) 1998-12-23
AU7312296A (en) 1997-05-07
CA2233160A1 (en) 1997-04-24
EP0863908A1 (en) 1998-09-16
KR19990064280A (en) 1999-07-26
JPH11513682A (en) 1999-11-24

Similar Documents

Publication Publication Date Title
US4804789A (en) D-mannite derivatives as starting products for the synthesis of phospholipids
AU697710B2 (en) Oxidation of phosphorus compounds
US4873355A (en) Process for regioselectively preparing phosphorylated inositols and other cyclitols
Ramirez et al. One-flask synthesis of unsymmetrical phosphodiesters. Selective amine catalysis of the phosphorylation of primary vs. secondary alcohols
WO1997014703A1 (en) Synthesis of polymerisable phosphodiesters
JPS6072899A (en) Manufacture of nucleosidoalkyl-, aralkyl- and allyl-phosphonite and -phosphonate
Derro et al. Synthesis of DL-2, 3-diacyloxypropylphosphonylcholines from DL-2, 3-diacyloxyiodopropanes
US2938902A (en) Novel pyridazinones and methods of preparing same
Kawashima et al. Optical resolution studies of cyclophosphamide
US4924023A (en) Phosphorylated inositols
US3632692A (en) Organophosphorus anhydrides
US6096916A (en) Synthesis of D-3 phosphorylated phosphoinositides and analogues
WO1998016535A1 (en) Synthesis of phosphorus compounds
EP0483732B1 (en) Phosphorylating agent and method for forming an asymmetric phosphodiester bond using the same
US3156718A (en) Process for preparing thiophosphoric, thiophosphonic, and thiophosphinic acid esters
US5254691A (en) Phosphorylating agent and method for forming phosphodiester bond using the same
US2956074A (en) Thiophosphoric acid esters
US4160773A (en) Synthetic alkyl esters of phospholipid acid, structural analogs thereof and a process for their manufacture and their use
US5026898A (en) Process for regioselectively preparing phosphorylated inositols and other cyclitols
Mushika et al. A New Phosphorylating Reagent. III. Preparation of Mixed Diesters of Phosphoric Acid by the Use of an Activatable Protecting Group
US6020506A (en) Synthesis of D-3 phosphorylated phosphoinositides and analogues
Wu et al. ASYMMETRIC SYNTHESIS OF (Rp)-AND (Sp)-2-ETHYL-,(Rp)-2-PENTYLOXY-,(Sp)-2-PENTYLTHIO-AND (Sp)-2-PENTYLAMINO-4 H-1, 3, 2-BENZODIOXAPHOSPHORIN 2-OXIDES
Tang et al. The isomerization/chlorination of 0, 0‐dialkyl methylthiophosphonates with phosphorus oxychloride—a new convenient synthesis of S‐alkyl methylthiophosphonic acid derivatives
Rosenthal 1347. An isosteric non-hydrolysable phosphatidic acid analogue
JP3619275B2 (en) Ascorbic acid phosphoramide derivative and method for producing the same

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired